MEDIROM Healthcare Technologies
MRM
1 hedge funds and large institutions have $143 invested in MEDIROM Healthcare Technologies in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 2 → 1 (-1)
56% less capital invested
Capital invested by funds: $323 → $143 (-$180)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$126 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$34 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $143 | -$126 | -25 | -50% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| – | -$34 | -6 | Closed |
|
MRM Hedge Fund Activity: Q4 2023 in Review
1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q4 2023, worth a combined $143 — down 56% from $323 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MRM and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Bank of America, cutting an estimated $126.
- 1 institutional investor held MEDIROM Healthcare Technologies (MRM) as of Q4 2023, down from 2 in Q3 2023.
- Funds reported $143 of MEDIROM Healthcare Technologies stock for Q4 2023, down 56% quarter-over-quarter.
- 0 funds opened new MEDIROM Healthcare Technologies positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest MEDIROM Healthcare Technologies seller in Q4 2023 was Bank of America, an estimated $126 sold.
Based on aggregated 13F filings for Q4 2023.